
Zhangzhou Pientzehuang's main business is pharmaceutical manufacturing, and its core medicine Pien Tze Huang holds state first-class protection.
zzpzh.comCrawled Nov 13, 2026
Zhangzhou Pien Tze Huang Pharmaceutical Co Ltd expands its business beyond traditional herbal formulas, introducing new products while maintaining its heritage in traditional Chinese medicine (TCM). The company leverages its long-standing reputation to broaden market reach and operational scope. Its established herbal formula remains a cornerstone of its offerings.
Oct 2025chinadaily.com.cnNews article
Zhangzhou Pien Tze Huang Pharmaceutical Co. Ltd. expands traditional Chinese medicine (TCM) globally by blending heritage practices with modern innovations. The company supports the Belt and Road Initiative while leveraging its established TCM assets to reach international markets. Its efforts align with broader Chinese pharmaceutical industry goals to integrate age-old remedies with contemporary advancements.
Nov 2024PR NewswireNews article
Zhangzhou Pien Tze Huang Pharmaceutical secures NMPA approval for clinical trials of **PZH2113**, a self-developed chemical drug targeting **recurrent/refractory non-Hodgkin’s lymphoma**, including diffuse large B-cell lymphoma. The company, a leader in traditional Chinese medicine, advances its first Category 1 drug into human testing under China’s regulatory framework.
Jun 2024Insight, China's Pharmaceutical IndustryNews article
Zhangzhou Pien Tze Huang Pharmaceutical Co. Ltd. and Beijing Tong Ren Tang Group signed a cooperation agreement to strengthen bilateral collaboration. The deal aims to advance the high-quality development of traditional Chinese medicine (TCM). The agreement was formalized during the First Conference of Partners of Tong Ren Tang in Beijing.
Feb 2024BioSpaceNews article